Search Login Register
6-Aminocaproic Acid
(6 Aminocaproic Acid)
Summary
Description:
An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Also Known As:
6 Aminocaproic Acid; Amicar; CY-116; Caprocid; Epsamon Show All >>
Networked: 422
relevant articles (31 outcomes,
40 trials/studies)
for this Drug
Key Diseases for which 6-Aminocaproic Acid is
Relevant
-
Hemorrhage
:
15 outcomes 11 studies in 130 results
-
Scoliosis
:
6 outcomes 5 studies in 9 results
-
Postoperative Hemorrhage
:
3 outcomes in 10 results
-
Heart Diseases (Heart Disease)
:
2 outcomes in 4 results
-
Wounds and Injuries (Trauma)
:
1 outcome 2 studies in 16 results
Show All >>
Drugs Related to 6-Aminocaproic Acid
-
Tranexamic Acid (AMCA)
-
Aprotinin (Trasylol)
-
Fibrinogen (Factor I)
-
6-Aminocaproic Acid (6 Aminocaproic Acid)
-
Heparin (Liquaemin)
-
Deamino Arginine Vasopressin (Desmopressin)
-
Lysine (L-Lysine)
-
Serine Proteases (Serine Protease)
-
Factor IX (PTC)
-
Dacarbazine (DIC)
Show All >>
Therapies Related to 6-Aminocaproic Acid
-
Spinal Fusion (Spondylosyndesis)
-
Cardiopulmonary Bypass (Heart-Lung Bypass)
-
Arthrodesis
-
Myocardial Revascularization
-
Extracorporeal Circulation
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.